Filing Flows › Eastman Chemical (EMN) › Q3 2026 › vs Q2 2026
Eastman Chemical (EMN) Q3 2026 vs Q2 2026 (quarter over quarter)
Eastman Chemical's revenue fell $128M (-5%) from $2.5B in Q2 2026 to $2.4B in Q3 2026. Gross margin 22.3% against 22.3% (+0.0 pts).
Eastman Chemical, Q3 2026: revenue $2.4B (+8% year over year), operating margin 10.4%, net earnings $253M, operating cash flow $290M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 22.3% | 22.3% | +0.0 pts |
| Operating margin | 10.4% | 10.2% | +0.3 pts |
| Net margin | 10.6% | 7.3% | +3.3 pts |
| Free cash flow margin | 8.2% | 4.9% | +3.2 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $2.4B | $2.5B | −$128M | -5% |
| Gross profit | $532M | $560M | −$28.0M | -5% |
| Cost of revenue | $1.9B | $2.0B | −$100M | -5% |
| Operating profit | $249M | $256M | −$7.0M | -3% |
| Operating expenses | $283M | $304M | −$21.0M | -7% |
| Pre-tax earnings | $249M | $256M | −$7.0M | -3% |
| Research & development | $63.0M | $65.0M | −$2.0M | -3% |
| SG&A | $171M | $185M | −$14.0M | -8% |
| Other operating costs | $49.0M | $54.0M | −$5.0M | -9% |
| Income tax benefit | $4.0M | −$72.0M | $76.0M | — |
| Net earnings | $253M | $184M | $69.0M | +38% |
| Depreciation & amortization | $134M | $132M | $2.0M | +2% |
| Share-based compensation | $16.0M | $19.0M | −$3.0M | -16% |
| Working capital & other | $113M | $111M | $2.0M | +2% |
| Operating cash flow | $290M | $224M | $66.0M | +29% |
| Free cash flow (OCF − capex) | $195M | $124M | $71.0M | +57% |
| Capital expenditures | $95.0M | $100M | −$5.0M | -5% |
Questions
How much did Eastman Chemical's revenue grow quarter over quarter in Q3 2026?
Eastman Chemical's revenue fell $128M (-5%) from $2.5B in Q2 2026 to $2.4B in Q3 2026. Gross margin 22.3% against 22.3% (+0.0 pts).